Retinopathy of prematurity (ROP) is a vascular proliferative disorder of retina, that causes visual impairment in premature children. Beside well known risk factors such as short gestational age, low birth weight and early oxygen exposure, genetic susceptibility is considered as a risk factor for development of the disease. The aim of our study was to explore the association of T-786C and 4a/b eNOS gene polymorphisms with the development of severe ROP. Study included 174 preterm infants, 84 with ROP and 90 as a control group. No differences have been observed in genotypes and alleles distributions of eNOS T-786C and eNOS 4a/b polymorphisms between two analyzed groups. There was significant difference in female infants by dominant model for 4a/b genotypes (4bb/4ba+4aa). Namely, female infants in ROP group were more frequently carriers of 4ba and 4aa genotypes than female infants in control group (p=0.037). Analysis of association between 4a/b eNOS polymorphism and ROP among preterm infants have not shown statistically significant association (p=0.288). Gestational age values by recessive model (4bb+4ba/4aa) were significantly lower in infants with 4aa genotype (t=2.034 708 GENETIKA, Vol. 48, No.2, 707-716, 2016 p=0.044). Almost all detected 4aa genotypes were present in the group of infants with gestational age under 30 weeks (p=0.032), but multivariate linear regression analysis does not show association of 4a/b genotypes with gestational age of premature infants. According to results of the present study T-786C and 4a/b polymorphisms of the eNOS gene may not be the risk factors for the manifestation of severe ROP in Serbian infants.
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Normal retinal vascularization occurs in the fetal environment and it is characterized by a relatively low oxygen level (GU et al. 2002) . After birth, premature neonates are exposed to a higher concentration of oxygen, which is required for their survival. In hyperoxic extrauterine environment normal vascularization in retina of premature infants is arrested and developed vessels undergo regression. Further development of retina results in maintaining avascular areas that become relatively hypoxic and abnormal retinal neovascularization is induced (GU et al. 2002) .
It is well known that nitric oxide (NO) mediates angiogenesis through vascular endothelial growth factor (VEGF) (PAPAPETROPOULOS et al. 1997) . Several studies described that long term VEGF exposure stimulates endothelial nitric oxide synthase (eNOS) to produce NO. eNOS plays a predominant role in hypoxia-induced angiogenesis and vascular permeability (MUROHARA et al. 1998 and FUKUMURA et al. 2001) . Deficiency of eNOS is responsible for retinal neovascularization (QAZI et al. 2009) .
eNOS is expressed primarily in endothelial cells and at low level in platelets (SASE et al. 1995) . Studies evaluating polymorphisms in specific candidate genes have demonstrated possible association between sequence variations and severity of ROP (COOKE et al. 2004) . Well known functional eNOS gene polymorphisms are T-786C in the promoter region and the variable 27-bp tandem repeat (VNTR) in intron 4 (eNOS 4a/b). These polymorphisms are responsible for the reduction of the endothelial NO synthesis and therefore alteration of the NO plasma levels.
The association between eNOS gene polymorphisms and the risk of severe ROP development has not been evaluated in the Serbian premature infants. Additionally, there has been no report dealing with the association between polymorphisms of eNOS gene and clinical risk factors of severe ROP expression, such as low birth weight and gestational age, low Apgar score and long period of oxygen therapy.
The aim of our study was to investigate whether T-786C and 4a/b eNOS gene polymorphisms are associated with severe ROP development in Serbian premature infants and to evaluate their influence on clinical risk factors of ROP.
MATERIALS AND METHODS
Study included 174 preterm infants borne at the Clinic of Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade. Selected babies had less than 2000 gr. at birth and gestational age below 35 weeks or higher birth weight and gestational age if they have had additional risk factors such as respiratory distress syndrome, anemia, intracranial hemorrhage and treatment with mechanical ventilation.
Clinical evaluation
Shown Apgar score was determined in the 5th minute. Intracranial hemorrhage (ICH) was determined by ultrasound of the central nervous system and graduated I-IV degrees according Papile (PAPILE et all. 1978) . Infants with stage III and IV were in ICH group. The degree of respiratory distress syndrome (RDS) was based on the assessment of Chest X-rays according to Bomsel (I-V degree) (BOMSEL 1970) . Hemoglobin less than 90 gr./L was the criterion for the anemia.
Ophthalmological screening for ROP was performed in all preterm infants by indirect binocular ophthalmoscope at the moment of maximum mydriasis. Preterm infants were divided into two groups according to the degree of ROP. The ROP group included infants with active form of the disease that required therapy. The control group included infants without signs of retinopathy and infants with retinopathy forms that did not require therapy.
Genotyping
All molecular genetic analyses were conducted at the Institute of Human Genetics, Faculty of Medicine, University of Belgrade. Genomic DNA was extracted from buccal swabs by phenol-chloroform method. Genotypes for eNOS T-786C polymorphism were detected by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Sequences of forward and reverse primers were 5′ GTG TAC CCC ACC TGC ATT CT 3′ and 5′ CCC AGC AAG GAT GTA GTG AC 3′, respectively. The products of PCR were digested with NaeI (PdiI) endonuclease. Results of digestion were: DNA fragments of 225 and 81 bp were present in case of CC genotype, 306, 225 and 81 bp long DNA fragments in CT genotype and in TT genotype a single undigested 306-bp long DNA fragment.
Genotypes of the eNOS intron 4 VNTR polymorphism were detected by PCR using forward 5′ CTA TGG TAG TGC CTT GGC TGG AGG 3′ and reverse 5′ ACC GCC CAG GGA ACT CCG CT 3′ primers. The DNA fragment 210 bp long corresponds with allele b (five 27-bp repeats) and 183-bp DNA fragment corresponds with allele a (four 27-bp repeats).
Statistical analysis
Differences in genotypes and alleles frequencies between ROP group and control group were analyzed by Chi-square test and Fisher exact test. Mean values were compared between genotype groups by ANOVA or Kruskal-Wallis test, depending on variable distribution. After grouping of genotypes (by dominant or recessive model) Student's t test and Mann-Whitney U test were used. Association between analyzed polymorphisms and ROP requiring treatment among preterm infants was explored by logistic regression analysis after the adjustment for gender, BMW, gestational age, Apgar score and days of oxygen therapy. Association analysis between analyzed polymorphisms and gestational age was performed by multivariate linear regression analysis with gender, BMW and Apgar score as covariates. Statistical analyses were performed using SPSS statistical package, version 16.0 (SPSS Inc, Chicago, IL, USA). Table 1 shows clinical data recognized as clinical risk factors for severe ROP development. Statistically significant differences were observed between ROP group and control group in mean values of gestational age, weight mass at birth, Apgar score and days of O2 therapy. Infants with gestational age bellow 32 weeks were present in group of ROP (89.2%) significant more frequently than in control group (74.4%) p=0.013. Also, frequencies of respiratory distress syndrome expression, broncho-pulmonary dysplasia, intracranial hemorrhage and requirement for mechanical ventilation were statistically significantly different between two analyzed groups of infants. Both analyzed genotypes in premature infants were in Hardy-Weinberg equilibrium. The differences in eNOS T-786C and eNOS 4a/b polymorphisms genotypes and alleles frequencies between two analyzed groups of premature infants were not statistically significant (Table 2) . Genotype frequencies between ROP and control groups by dominant 4bb/4ba+4aa, p=0.921; TT/ TC+CC, p=0.838) or recessive (4bb+4ba/4aa, p=0.435; TC+TT/CC, p=0.176) model did not show significant differences. Statistically significant difference was observed only in female infants by dominant model (4bb/4ab+4aa) (Fig. 1) . Female infants in ROP group were more often carriers 4ba and 4aa genotypes than female infants in control group (X2=4.333, p=0.037; Risk ratio 1.6849, CI 0.95, 0.962-2.951). We analyzed association between 4a/b eNOS polymorphism and ROP requiring treatment among preterm infants by logistic regression analysis. After the adjustment for gender, BMW, gestational age, Apgar score and days of oxygen therapy, logistic regression does not show statistically significant association between 4a/b genotypes and development of severe ROP in premature infants (β=0.346, p=0.288). DISCUSSION ROP occurs because abnormal blood vessels grow and spread throughout the retina. These blood vessels are fragile and can lead to retinal scarring and detachment. Retinal detachment is the main cause of visual impairment in ROP. Clinical characteristics contributing to the risk of ROP include gender, low birth weight, breathing difficulties, respiratory distress, anemia, blood transfusions, intracranial hemorrhage and the long period of oxygen therapy given to premature infants (KIM et al. 2004) , but the most important is gestational age at the moment when a baby was born. Prematurity is the reason why retina does not finish complete development and instead undergoes to neovascularisation typical for ROP (QAZI et al. 2009 ).
RESULTS
According to our study all clinical data, except gender, recognized as postnatal clinical risk factors, are statistically significantly different between two analyzed groups of infants. This result was expected and described previously in our population (KNEŽEVIĆ et al. 2011) . It is observed that the severe stage of ROP progresses in some and regresses spontaneously in others infants with similar clinical findings. It has been reported that genetic factors may influence the progression of the severe stage of ROP among infants with similar clinical findings (VANNAY et al. 2005) . BIZZARRO et al. (2006) reported that genetic factors accounted for 70.1% of the variance in liability for retinopathy of prematurity. Genetic polymorphisms may alter the function of the genes that normally contribute to angiogenesis in retina, such as VEGF and eNOS. Published data in different populations described conflicting results considering genetic polymorphisms in VEGF gene. Some of them support the hypothesis that VEGF gene polymorphisms are associated with progression of ROP to the advanced stage (VANNAY et al. 2005 and LIU et al. 2012) , but others did not find any association with ROP development (DUNAI et al. 2008 , KALMEH et al. 2013 , and MALIK et al. 2014 .
eNOS gene polymorphisms were determined as risk factors for retinopathy with similar pathogenesis like ROP. Published data suggest that genetic polymorphisms Glu298Asp, 4b/a and T-786C (EZZIDI et al. 2008) and C774T (TAVERNA et al. 2005) in the eNOS gene are genetic risk factors for diabetic retinopathy. These polymorphisms may be useful markers of increased susceptibility to severe diabetic retinopathy. Only two studies analyzed eNOS gene polymorphisms in etiology of ROP. One study identified minor -786C and 894T alleles of eNOS gene as significant risk factors in the development of ROP, and found strong association between those eNOS gene polymorphisms and the severity of disease in Caucasians and African Americans (YANAMANDRA et al. 2010) . RUSAI et al. (2008) observed that the genotype distribution of eNOS 4a/b polymorphism was significantly different in preterm infants with severe ROP compared to preterm infants with ROP stage that did not require treatment. They emphasized eNOS 4aa genotype as an independent risk factor for severe ROP. In the same study association between eNOS T-786C and ROP has not been observed. Results of our study show that no differences in genotypes and alleles distributions of eNOS T-786C and eNOS 4a/b polymorphisms between two analyzed groups of premature infants. We found that only female infants in ROP group were more often carriers of 4ba and 4aa genotypes than female infants in the control group. RUSAI et al. (2008) described mail gender as risk factor for severe ROP development, but our results did not show differences in gender distribution between ROP and control group. Also, logistic regression analysis did not show association between 4a/b genotype and severe ROP development after adjustment for significant clinical risk factors (gender, BMW, gestational age, Apgar score and days of oxygen therapy).
Recent studies show significant associations between the eNOS (Glu298Asp) polymorphism and idiopathic recurrent pregnancy loss (SU et al. 2011 ) and found significantly higher frequencies of mutant allele in spontaneously aborted fetal materials (YALCINTEPE et al. 2015) . GIBSON et al. (2007) reported that polymorphisms of nitric oxide are associated with prematurity and suggest that they may be contributors to the risk of spontaneous preterm birth. Our results show that almost all detected 4aa genotypes (5 of 6) were present in the group of infants with gestational age under 30 weeks. This polymorphism was not investigated as a risk factor for spontaneous preterm birth in the literature. Multivariate linear regression analysis in our study did not show association of 4a/b genotypes with gestational age of premature infants.
We can conclude that in Serbian premature infants T-786C and 4a/b eNOS gene polymorphisms were not associated with development of severe ROP. Some association was detected for 4a/b genotypes in female gender but was not sufficient to conclude that minor allele was the risk factor for severe ROP development in female infants. Also, according to our study, T-786C and 4a/b eNOS gene polymorphisms are not relevant to the prediction of prematurity. In mulifactorial trait such as ROP, expression of phenotype depends on interaction of many genes and influence of the environment. According to all this, to predict severe ROP development it may be necessary to analyze more genes in a larger cohort of ROP patients.
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ISPITIVANJE POLIMORFIZAMA T-786C I 4A/B U GENU ZA ENDOTELNU AZOT
OKSID SINTETAZU KOD DECE SA RETINOPATIJOM PREMATURITETA
